Blueprint Medicines Corp
Total Trades
115
Buys
3
Sells
82
Largest Trade
N/A
Insiders
15
Institutional Funds
2
Inst. Value
$50K–$100K
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Hurley Ariel | PRINCIPAL ACCOUNTI… | EXERCISE | $1K–$15K | 714 | $8.80 | Dec 26, 2023 |
| Albers Jeffrey W. | Director | SELL | $100K–$500K | 5K | $70.55 | Dec 4, 2023 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 5K | $36.05 | Dec 4, 2023 |
| Albers Jeffrey W. | Director | EXERCISE | $15K–$50K | 15K | $1.87 | Nov 28, 2023 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 15K | $67.51 | Nov 28, 2023 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 10K | $60.20 | Nov 3, 2023 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 10K | $36.05 | Nov 3, 2023 |
| Murray Christopher K. | CHIEF TECHNICAL OP… | SELL | $15K–$50K | 600 | $56.40 | Oct 30, 2023 |
| Namouni Fouad | PRESIDENT, R & D | SELL | $100K–$500K | 4K | $48.06 | Oct 5, 2023 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 25K | $49.76 | Sep 29, 2023 |
| Albers Jeffrey W. | Director | EXERCISE | $15K–$50K | 25K | $1.87 | Sep 29, 2023 |
| Albers Jeffrey W. | Director | EXERCISE | $15K–$50K | 25K | $1.87 | Aug 28, 2023 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 25K | $49.81 | Aug 28, 2023 |
| Carter Percy H. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 2K | $52.06 | Jun 7, 2023 |
| Hewes L. Becker | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 1K | $52.05 | Jun 7, 2023 |
| Murray Christopher K. | CHIEF TECHNICAL OP… | SELL | $50K–$100K | 2K | $45.68 | Mar 9, 2023 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $100K–$500K | 3K | $45.67 | Mar 9, 2023 |
| Namouni Fouad | PRESIDENT, R & D | SELL | $50K–$100K | 2K | $45.68 | Mar 9, 2023 |
| Hewes L. Becker | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 2K | $45.69 | Mar 9, 2023 |
| Lee Philina | CHIEF COMMERCIAL O… | SELL | $50K–$100K | 2K | $45.68 | Mar 9, 2023 |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | SELL | $100K–$500K | 3K | $45.68 | Mar 9, 2023 |
| Carter Percy H. | CHIEF SCIENTIFIC O… | SELL | $15K–$50K | 761 | $45.69 | Mar 9, 2023 |
| Albers Jeffrey W. | Director | SELL | $100K–$500K | 10K | $45.67 | Mar 9, 2023 |
| McCain Tracey L | EVP AND CHIEF LEGA… | SELL | $100K–$500K | 3K | $45.68 | Mar 9, 2023 |
| Landsittel Michael | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 3K | $45.68 | Mar 9, 2023 |
| Hurley Ariel | PRINCIPAL ACCOUNTI… | SELL | $50K–$100K | 1K | $45.68 | Mar 9, 2023 |
| Haviland Kate | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 7K | $45.69 | Mar 9, 2023 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 20K | $50.09 | Dec 8, 2022 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 20K | $8.44 | Dec 8, 2022 |
| Rossi Christina | CHIEF OPERATING OF… | SELL | $15K–$50K | 533 | $45.24 | Nov 7, 2022 |
| Haviland Kate | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 1K | $43.98 | Nov 7, 2022 |
| Namouni Fouad | PRESIDENT, R & D | SELL | $100K–$500K | 3K | $67.30 | Oct 5, 2022 |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | EXERCISE | $50K–$100K | 5K | $15.01 | Aug 26, 2022 |
| Durso-Bumpus Debra | CHIEF PEOPLE OFFICER | SELL | $100K–$500K | 5K | $75.11 | Aug 26, 2022 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 10K | $15.01 | Aug 23, 2022 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 10K | $70.45 | Aug 23, 2022 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 20K | $68.41 | Aug 18, 2022 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 20K | $8.44 | Aug 18, 2022 |
| Albers Jeffrey W. | Director | EXERCISE | $50K–$100K | 10K | $6.84 | Aug 10, 2022 |
| Albers Jeffrey W. | Director | SELL | $500K+ | 10K | $70.07 | Aug 10, 2022 |
| Murray Christopher K. | SVP | SELL | $100K–$500K | 5K | $62.72 | Aug 8, 2022 |
| Demetri George | Director | BUY | <$1K | 10 | $82.66 | Jul 1, 2022 |
| Demetri George | Director | GRANT | N/A | 3K | — | Jul 1, 2022 |
| Demetri George | Director | SELL | <$1K | 10 | $58.56 | Jul 1, 2022 |
| Carter Percy H. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 2K | $59.76 | Jun 8, 2022 |
| Hewes L. Becker | CHIEF MEDICAL OFFI… | SELL | $100K–$500K | 4K | $59.93 | Jun 8, 2022 |
| Albers Jeffrey W. | Director | SELL | $1M+ | 20K | $55.89 | May 18, 2022 |
| Albers Jeffrey W. | Director | EXERCISE | $100K–$500K | 20K | $8.44 | May 18, 2022 |
| Albers Jeffrey W. | CEO AND PRESIDENT | EXERCISE | $50K–$100K | 5K | $15.01 | Apr 8, 2022 |
| Albers Jeffrey W. | CEO AND PRESIDENT | SELL | $100K–$500K | 5K | $70.11 | Apr 8, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 733 | $50K–$100K | SH |
| HUNTINGTON NATIONAL BANK | 1 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Pentwater Capital Management LP
SC 13G · Aug 14, 2025
6.0%
3.9M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Aug 14, 2025
2.3%
1.5M shares
SC 13G/A · Aug 14, 2025
0.6%
375K shares
SC 13G · Jul 21, 2025
0.0%
0 shares
SC 13G · May 15, 2025
6.0%
3.9M shares
Wellington Management Group LLP
SC 13G/A · May 12, 2025
4.8%
3.1M shares
SC 13G/A · Apr 24, 2025
8.0%
5.1M shares
SC 13G/A · Feb 12, 2025
3.5%
2.2M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
8.5%
5.4M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Apr 10, 2024
10.2%
6.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
8.9%
5.4M shares
SC 13G/A · Jan 24, 2024
10.8%
6.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Jan 10, 2024
10.1%
6.1M shares
SC 13G/A · Nov 13, 2023
7.7%
4.7M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
7.2%
4.3M shares
SC 13G/A · Jan 26, 2023
10.5%
6.3M shares
SC 13G/A · Jan 20, 2023
10.5%
6.3M shares
SC 13G/A · Nov 9, 2022
10.0%
6.0M shares
SC 13G · May 10, 2022
10.1%
6.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
7.7%
4.6M shares